Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 8/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13920082 | 0.82 | PTGDR2 (0.35) | PTGDR2KDM4EPOLBMAPTMEN1 | |
| SCHEMBL873381 | 0.76 | PTGDR2 (0.53) | PTGDR2KDM4EPOLBMAPTMEN1 | |
| SCHEMBL5026007 | 0.73 | CYP1A2 (0.54) | MAPTMEN1KMT2AALDH1A1CYP1A2 | |
| SCHEMBL6739260 | 0.73 | PTGDR2 (0.40) | PTGDR2KDM4EPOLBMAPTMEN1 | |
| SCHEMBL1158268 | 0.73 | PTGDR2 (0.40) | PTGDR2KDM4EPOLBMAPTMEN1 | |
| SCHEMBL11150044 | 0.73 | ALDH1A1 (0.53) | PTGDR2KDM4EPOLBMAPTMEN1 | |
| SCHEMBL10360134 | 0.71 | PTGDR2 (0.39) | PTGDR2KDM4EPOLBMAPTMEN1 | |
| SCHEMBL13301451 | 0.71 | MEN1 (0.41) | PTGDR2KDM4EPOLBMAPTMEN1 | |
| Bromide SCHEMBL11363387 | 0.71 | CYP1A2 (0.53) | MAPTMEN1KMT2AALDH1A1CYP1A2 | |
| SCHEMBL5516134 | 0.70 | PTGDR2 (0.40) | PTGDR2KDM4EPOLBMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1408093-B1 | COLORED IMAGE-FORMING COMPOSITIONS CONTAINING PHTHALOCYANINE COMPOUND, INKS, INKJET INKS, INKJET RECORDING METHOD AND METHOD OF IMPROVING TOLERANCE TO DECOLORATION DUE TO OZONE GAS | FUJIFILM CORP (JP) | 2018-02-21 | — | — | EP | disclosed |
| EP-1770133-B1 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM CORP (JP) | 2015-03-11 | — | — | EP | disclosed |
| US-7816422-B2 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM CORPORATION (JP) | 2010-10-19 | — | — | US | disclosed |
| US-20100136300-A1 | CURABLE COMPOSITION, INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING PLATE AND OXETANE COMPOUND | FUJIFILM CORPORATION (JP) | 2010-06-03 | — | — | US | disclosed |
| US-7709550-B2 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20070132810-A1 | Ink composition, inkjet recording method, printed material, production method of planographic printing plate, and planographic printing plate | FUJIFILM CORPORATION (JP) | 2007-06-14 | — | — | US | disclosed |
| EP-1770133-A1 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM Corporation (JP) | 2007-04-04 | — | — | EP | disclosed |
| US-20070071952-A1 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| US-20070052790-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. | 2007-03-08 | — | — | US | disclosed |
| US-20070049651-A1 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, planographic printing plate, and oxcetane compound | FUJI PHOTO FILM CO., LTD. | 2007-03-01 | — | — | US | disclosed |
| EP-1757635-A1 | Curable modified oxetane compound and ink composition comprising it | Fuji Photo Film Co., Ltd. (JP) | 2007-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100136300-A1 | CURABLE COMPOSITION, INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING PLATE AND OXETANE COMPOUND | CCNT1, ACVR2B, ACVR1B | PTGDR2 434/4885KDM4E 10/4885POLB 2846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.